GlassScriptPhysician profile
Daphne Pinkas
NPI 1407152341
$1,303.46
in general payments reported to CMS, 2019-2025
14 companies · $466 in 2025
The $466 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2021: $200 · 2024: $424 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $890.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $889.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $319.01 | 2024-2025 | Aequalis Perform Reversed, Gamma, T2 Alpha |
| Smith+Nephew, INC. | $249.66 | 2021-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Medtronic, INC. | $171.60 | 2025 | Kyphon Express II Kyphopak Tray |
| Seapearl East, INC | $109.25 | 2019 | |
| Acumed LLC | $85.64 | 2025 | Acumed, Innate Implant |
| Boston Scientific Corporation | $75.00 | 2019 | |
| Coastal Medical Technologies LLC | $72.17 | 2025 | |
| Depuy Synthes Sales INC. | $59.67 | 2024 | Healix Knotless Peek, Dynacord, Truespan Orthocord |
| Anika Therapeutics, INC. | $36.23 | 2024 | Integrity, Ovomotion |
| Glaxosmithkline, LLC. | $28.86 | 2019 | |
| Amgen INC. | $28.82 | 2024 | Krystexxa |
| Endo USA, INC. | $23.57 | 2024 | Xiaflex |
| Endo Pharmaceuticals INC. | $23.37 | 2024 | Xiaflex |
| Orthofix Medical, INC. | $20.61 | 2024 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daphne Pinkas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.